BioFocus DPI and The ALS Association announce €2.4 million target discovery alliance 11-12-2006
Mechelen, Belgium and Calabasas Hills, CA, USA; 11 December 2006 – Galapagos NV (Euronext & LSE: GLPG) and The ALS Association, a non-profit health organization dedicated to finding a cure for amyotrophic lateral sclerosis (ALS), announced today...
» read more
Inpharmatica acquisition adds breadth and depth to BioFocus DPI offering 6-12-2006
Mechelen, Belgium, and London, UK, 6 December, 2006; Galapagos NV (Euronext & London AIM: GLPG), an integrated drug discovery company, and UK-based Inpharmatica Ltd. today announced that they have entered into a definitive agreement under which...
» read more